Company Overview:
Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva’s wholly owned subsidiary is licensed under the Cannabis Act. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.
[stock_market_chart symbol=”NDVA.V” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]
Key Share Information:
Current Share Price $0.36
Market Capitalization (in Millions) $29.89
Last Quarter (Share Data) 3/31/2019
Shares Outstanding (in Millions) 83.04
Options (in Millions) 4.22
Warrants (in Millions) 27.29
Fully Diluted (in Millions) 114.54
Enterprise Value (in MIllions) $28.03
TTM Revenue $0.34
TTM Growth Margin % -79.09%
TTM Operating Expenses $16.22
TTM OCF -$1.76
P/S TTM 86.65
P/S (Last Quarter Run Rate) 26.07
Key Balance Sheet Information (in Millions $CAD):
CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ1'19
Cash $0.04 $0.02 $0.10 $0.06 $21.30 $33.09 $27.25 $24.31 $19.57 $8.16
Biological Assets $0.09 $0.12
Inventory $0.28 $0.68 $1.16 $1.44
Total Assets $0.26 $0.24 $0.32 $0.15 $27.55 $39.72 $38.27 $37.43 $35.85 $32.20
Net Tangible Assets $0.26 $0.24 $0.32 $0.15 $27.45 $39.60 $38.11 $37.27 $35.50 $31.90
Intangibles/Goodwill $0.09 $0.12 $0.16 $0.15 $0.35 $0.30
Total Liabilities $0.15 $0.15 $0.03 $0.02 $8.73 $5.65 $6.06 $5.74 $6.45 $6.30
Key Operating Items (Quarterly in Millions $CAD):
CYQ4'16 CYQ1'17 CYQ2'17 CYQ3'17 CYQ4'17 CYQ1'18 CYQ2'18 CYQ3'18 CYQ4'18 CYQ1'19
Revenue $0.00 $0.06 $0.29
Change in Fair Value of Biologial Assets 0.02 0.10 $0.08
Gross Margin -0.29 0.10 -$0.09
Marketing and Sales $0.27 $0.15 $0.21 0.06 0.61 $0.13
Investor Relations $0.00 $0.00 $0.00 $0.00 $0.06 $0.10 0.10 0.39 $0.11
Total Operating Expenses $0.31 $0.02 $0.02 $0.24 $3.03 $2.05 $2.06 1.66 8.87 $3.63
Operating Cash Flow (Quarterly) -$0.23 -$0.16 $0.01 -$0.03 -$4.04 -1.49 -2.67 $6.44
Investing Cash Flow (Quarterly) -$0.17 $0.00 $0.00 $0.00 -$1.49 -1.43 -1.81 -$3.21
Financing Cash Flow (Quarterly) $0.29 $0.24 -$0.05 $7.04 -$0.31 -0.03 -0.26 -$12.90
Listing Statement
